$SPPI
Spectrum Pharmaceuticals Inc.
PRICE
$3.38 ▼-0.88%
Last Close
VOLUME
2,483,515
DAY RANGE
3.29 - 3.45
52 WEEK
1.74 - 10.57
Echofin Members Consensus
jcarlgohn #StockTraders.NET Join team
soheil.n #StockTraders.NET Join team
i waited too long for $sppi for a bounce that never came...seeing a trend recently some just don't bounce
maletone #StockTraders.NET Join team
yup i wanted $SPPI too
brAli #StockTraders.NET Join team
i reall wanted tht $sppi to pop HOD
brAli #StockTraders.NET Join team
Key Metrics
Market Cap
492.58 M
Beta
0.39
Avg. Volume
2.94 M
Shares Outstanding
145.73 M
Yield
0%
Public Float
143.18 M
Next Earnings Date
2020-11-04
Next Dividend Date
Company Information
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.
CEO: Joseph W. Turgeon
Website: http://www.sppirx.com
HQ: 11500 South Eastern Avenue Henderson, 89052 NV
Related News
-
Neutropenia Treatment Market Top Key Players- Enzychem Lifesciences Corporation, Spectrum Pharmaceuticals, Inc., Tianjin SinoBiotech Ltd., S&D Pharma SK s.r.o., Samsung Medical Center Growth Trends, quantitative analysis Industry Analysis and Market Dynam
27 Oct 2020, 11:17 -
Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)
26 Oct 2020, 11:00 -
Pfizer's COVID-19 Vaccine Candidate Primed For $3.5B In 2021 Sales: Analyst
21 Oct 2020, 14:45 -
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September
08 Sep 2020, 11:00 -
Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update
03 Aug 2020, 11:00